Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jan;35(1):155-167.
doi: 10.1177/0891988720988901. Epub 2021 Jan 28.

Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson's

Angeliki Bogosian  1 , Catherine S Hurt  1 , John V Hindle  2 , Lance M McCracken  3 , Debora A Vasconcelos E Sa  1 , Sandra Axell  1 , Katy Tapper  4 , Jemima Stevens  4 , P Shashi Hirani  1 , Marya Salhab  1 , Wenrong Ye  5 , Patricia Cubi-Molla  6
Affiliations
Randomized Controlled Trial

Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson's

Angeliki Bogosian et al. J Geriatr Psychiatry Neurol. 2022 Jan.

Abstract

Mindfulness-based group therapy is a rapidly growing psychological approach that can potentially help people adjust to chronic illness and manage unpleasant symptoms. Emerging evidence suggests that mindfulness-based interventions may benefit people with Parkinson's. The objective of the paper is to examine the appropriateness, feasibility, and potential cost-effectiveness of an online mindfulness intervention, designed to reduce anxiety and depression for people with Parkinson's. We conducted a feasibility randomized control trial and qualitative interviews. Anxiety, depression, pain, insomnia, fatigue, impact on daily activities and health-related quality of life were measured at baseline, 4, 8, and 20 weeks. Semi-structured interviews were conducted at the end of the intervention. Participants were randomized to the Skype delivered mindfulness group (n = 30) or wait-list (n = 30). Participants in the mindfulness group were also given a mindfulness manual and a CD with mindfulness meditations. The intervention did not show any significant effects in the primary or secondary outcome measures. However, there was a significant increase in the quality of life measure. The incremental cost-effectiveness ratio was estimated to be £27,107 per Quality-Adjusted Life Year gained. Also, the qualitative study showed that mindfulness is a suitable and acceptable intervention. It appears feasible to run a trial delivering mindfulness through Skype, and people with Parkinson's found the sessions acceptable and helpful.

Keywords: EQ-5D; Parkinson’s; anxiety; depression; mindfulness.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
CONSORT flow diagram.
Figure 2.
Figure 2.
Change in health-related quality of life (HRQoL) in the mindfulness (MBI) and wait-list control (WLC) group.
See this image and copyright information in PMC

References

    1. Burn DJ. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson’s disease. Mov Disord. 2002;17(3):445–454. doi:10.1002/mds.10114 - PubMed
    1. Brown RG, Landau S, Hindle JV, et al. Depression and anxiety related subtypes in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2011;82(7):803–809. doi:10.1136/jnnp.2010.213652 - PubMed
    1. Kampling H, Brendel LK, Mittag O. (Neuro)Psychological interventions for non-motor symptoms in the treatment of patients with Parkinson’s disease: a systematic umbrella review. Neuropsychol Rev. 2019;29(2):166–180. doi:10.1007/s11065-019-09409-4 - PubMed
    1. Ghielen I, Rutten S, Boeschoten RE, et al. The effects of cognitive behavioral and mindfulness-based therapies on psychological distress in patients with multiple sclerosis, Parkinson’s disease and Huntington’s disease: two meta-analyses. J Psychosom Res. 2019;122:43–51. doi:10.1016/j.jpsychores.2019.05.001 - PubMed
    1. Yang S, Sajatovic M, Walter BL. Psychosocial interventions for depression and anxiety in Parkinson’s disease. J Geriatr Psychiatry Neurol. 2012;25(2):113–121. doi:10.1177/0891988712445096 - PubMed

Publication types